ESPR—Lively debate on Twitter about the ramifications of these data and whether LDL will continue to be an accepted biomarker if MRK’s IMPROVE-IT study fails.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.